Cervical cancer (CC) is a major gynecological problem in developing and underdeveloped
countries. Despite the significant advancement in early detection and treatment modalities …

Simple Summary Despite the implementation of efficient screening and vaccination
programs, uterine cervical cancer remains a leading cause of cancer-related mortality in …

The management of recurrent cervical cancer depends mainly on previous treatment and on
the site and extent of recurrence. Concurrent cisplatin-based chemo-radiation is the …

Abstract Treatment failure is one of the main hurdles in treating cervical cancer, despite
significant breakthroughs in both conventional and targeted therapy. The one-year survival …

Invasive cervical cancer remains an important global cause of death, despite the declining
prevalence within the United States. Definitive therapies, including surgical resection of …

Objective The objective of the present study was to provide genomic and transcriptomic
information that may improve clinical outcomes for locally advanced cervical cancer (LACC) …

It is estimated that 604,127 patients were diagnosed with cervical cancer worldwide in 2020.
While a small percentage of patients will have metastatic disease at diagnosis, a large …

Cervical cancer is the third most common cancer worldwide, and the development of new
diagnosis, prognostic, and treatment strategies is a major interest for public health. Cisplatin …

Cervical cancer (CC) constitutes a serious public health problem. Vaccination and screening
programs have notably reduced the incidence of CC worldwide by> 80%; however, the …

Cervical cancer (CC) as a single diagnostic entity exhibits differences in clinical behavior
and poor outcomes in response to therapy in advanced tumors. Although infection of high …